FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

22324711000001102: Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73623501000001117 Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73623601000001118 Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Is a Product containing precisely carvedilol 6.25 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has active ingredient Carvedilol false Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has specific active ingredient Carvedilol true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) 28 tablet 2 x 14 tablets Has AMP True Carvedilol 6.25mg tablets (APC Pharmaceuticals & Chemicals (Europe) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start